GLP-1 receptor agonists remain blockbuster drugs for weight management for people with overweight or obesity. Increasingly, ...

Findings showed a 13.6% reduction in body weight in the semaglutide 25mg group compared with a 2.2% ... in adults with overweight or obesity and established cardiovascular disease. The NDA is ...